Purtscher-like retinopathy as the manifestation of adult Still’s disease

oc000257 10.3205/oc000257 urn:nbn:de:0183-oc0002570 Case Report Purtscher-like retinopathy as the manifestation of adult Still’s disease Castro de Oliveira Figueiroa Castro de Oliveira Figueiroa Maria Lourdes ML

Escola Bahiana de Medicina e Saúde Pública, Salvador, Bahia, Brazil

author Chagas Oliveira Chagas Oliveira Ricardo Danilo RD

Division of Ophthalmology, Faculdade de Medicina da Universidade Federal da Bahia, Salvador, Bahia, Brazil

author Behrens Pinto Behrens Pinto Gustavo Luiz GL

Division of Rheumatology, Faculdade de Medicina da Universidade Federal da Bahia, Salvador, Bahia, Brazil

author Moura Costa Campos Moura Costa Campos Maria Carolina MC

Division of Gastroenterology, Escola Paulista de Medicina da Universidade Federal de São Paulo, São Paulo, Brazil

author David da Silva Viana David da Silva Viana Lizandra Almeida LA

Division of Ophthalmology, Faculdade de Medicina da Universidade Federal da Bahia, Salvador, Bahia, Brazil

author Prado Viana Prado Viana Izabela I

Faculdade de Medicina da Universidade Federal da Bahia, R. Dr. Augusto Viana – Canela, Salvador, 40110-060, Bahia, BrazilDivision of Rheumatology, Faculdade de Medicina da Universidade Federal da Bahia, Salvador, Bahia, Brazil

izabela.viana@live.com author Barreto Santiago Barreto Santiago Mittermayer M

Division of Rheumatology, Faculdade de Medicina da Universidade Federal da Bahia, Salvador, Bahia, Brazil

author German Medical Science GMS Publishing House

Düsseldorf

610 adult-onset Still’s disease Purtscher-like retinopathy ocular involvement infliximab 20251002 engl This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). 2193-1496 15 GMS Ophthalmology Cases GMS Ophthalmol Cases 09 Adult Still’s disease (ASD) is a rare systemic inflammatory disorder for which ocular manifestations have rarely been described. We report a case of 38-year-old Brazilian woman with Purtscher-like retinopathy as a manifestation of ASD. She was diagnosed with Purtscher-like retinopathy based on fundoscopic findings, which revealed vasculitis with diffuse and bilateral perimacular cotton-wool exudates. She also p</PlainText></TextGroup>resented with fever, arthritis, weight loss, and a diffuse cutaneous rash. Considering the severity of the retinopathy, she was initially treated with methylprednisolone pulse therapy and oral methotrexate, and later with infliximab, with the treatment changing due to partial recovery of vision loss. Purtscher-like retinopathy is a poor prognostic factor for ASD, as it can lead to permanent visual damage. Thus, early and aggressive immunosuppressive therapy is mandatory.</Pgraph></Abstract> <TextBlock name="Introduction" linked="yes"> <MainHeadline>Introduction</MainHeadline><Pgraph>Purtscher’s retinopathy is a rare condition first described in 1910 in a patient with reduced post-traumatic visual acuity who exhibited hemorrhages and retinal clearing <TextLink reference="1"></TextLink>. Although primarily associated with trauma, some systemic conditions can lead to a similar retinopathy, known as Purtscher-like retinopathy <TextLink reference="2"></TextLink>. Among these conditions, acute pancreatitis, renal disease, thrombotic microangiopathies, cholesterol emboli, cryoglobulinemia, and diffuse connective tissue diseases (DCTDs), specifically systemic lupus erythematosus, systemic sclerosis, and dermatomyositis, stand out <TextLink reference="2"></TextLink>, <TextLink reference="3"></TextLink>.</Pgraph></TextBlock> <TextBlock name="Case description" linked="yes"> <MainHeadline>Case description</MainHeadline><Pgraph>Here, we present an exceptional case of Purtscher-like retinopathy with severe visual impairment as a manifestation of adult Still’s disease (ASD). A 38-year-old Brazilian woman, who was otherwise previously healthy, was admitted to our hospital complaining of intermittent fever, odynophagia associated with a weight loss of 15 kg, and polyarthritis of the hands, wrists, and knees for the last five months. During this period, she also developed a rapid progressive reduction of visual acuity bilaterally and reported recurrent chronic urticaria three months ago, with disseminated erythematous lesions refractory to the use of antihistamines and oral corticosteroids. She denied alcoholism, smoking, or illicit drug use. She had no previous hospitalization or family history of inflammatory disease. On physical examination, she had evanescent skin erythematous plaques on her trunk and limbs, in addition to tenderness in the joints of her hands, feet, and knees, albeit without swelling. Mild splenomegaly was also noted. No palpable hepatomegaly or adenomegaly was observed. Laboratory workup showed mild anemia without hemolysis pattern, neutrophilic leukocytosis, and normal platelet count. C-reactive protein and ferritin levels were elevated. Renal, hepatic, and pancreatic functions were normal. Autoantibodies and infectious tests were negative, as shown in Table 1 <ImgLink imgNo="1" imgType="table" />. Additional evaluation with a tomographic study of the chest and abdomen revealed no abnormalities. Ophthalmologic examination showed visual acuity of counting fingers at 30 cm in both eyes. External examination revealed orthotropic eyes with full extraocular movements and intact motor reflexes. Anterior segment evaluation showed quiet eyes with clear corneas, well-formed and deep anterior chambers, iris without abnormalities, and a phakic lens. There were no signs of anterior chamber inflammation, and the vitreous was clearly visible. Funduscopic examination revealed vasculitis with diffuse bilateral perimacular cotton-wool exudate (Figure 1 <ImgLink imgNo="1" imgType="figure" />). A complementary study with fluoresce<TextGroup><PlainText>in an</PlainText></TextGroup>giography revealed delayed circulatory times in all phases of the angiogram, early hypofluorescence, slower filling of vessels, and late leakage, similar to the symptoms of Purtscher-like retinopathy (Figure 2 <ImgLink imgNo="2" imgType="figure" />). </Pgraph><Pgraph>Because other systemic disorders were excluded, the patient was diagnosed with ASD according to Yamaguchi’s criteria. Pulse therapy was initiated with 1 g methylprednisolone for three days, followed by 1 mg/kg of prednisone daily and oral methotrexate (15 mg/week) with gradual remission of systemic inflammatory activity. In addition, endolaser photocoagulation was performed. Ophthalmological reassessment one month later showed a slight reduction in diffuse and perimacular cotton-wool exudates. Immunobiological treatment was thus initiated with infliximab intravenously administered at 3 mg/kg, at weeks zero, two, six, and every eight weeks thereafter, with the treatment changing due to partial recovery of her vision. At the last evaluation, after 25 months of fo<TextGroup><PlainText>llo</PlainText></TextGroup>w-up, the patient’s best-corrected visual acuity was 20/200 in both eyes.</Pgraph></TextBlock> <TextBlock name="Discussion" linked="yes"> <MainHeadline>Discussion</MainHeadline><Pgraph>Ocular involvement in ASD occurs in approximately 5% of patients, mainly in those with a severe systemic presentation <TextLink reference="4"></TextLink>. The main manifestations are sicca syndrome, uveitis, episcleritis, inflammatory orbit<TextGroup><PlainText>al ps</PlainText></TextGroup>eudotumor, ptosis, diplopia, and nystagmus <TextLink reference="5"></TextLink>, <TextLink reference="6"></TextLink>. Purtscher-like retinopathy associated with ASD is a rare condition <TextLink reference="6"></TextLink>. In medical literature, we found only nine additional cases, consisting of five men and four women with a mean age of 33 years, most of whom had early ocular involvement and conditions associated with thrombotic microangiopathy (TMA) <TextLink reference="4"></TextLink>, as shown in Table 2 <ImgLink imgNo="2" imgType="table" />. In the present case, the laboratory data and physical examinations did not fulfill the TMA criteria. Buyukavsar et al. also reported Purtscher-like retinopathy without TMA in a patient with ASD who was successfully treated with a high dose of oral prednisolone <TextLink reference="7"></TextLink>. Therefore, in cases where Purtscher-like retinopathy is manifested early, as in our case, systemic immunosuppressive therapy may prevent the onset of TMA <TextLink reference="8"></TextLink>.</Pgraph><Pgraph>Purtscher’s retinopathy may present with visual field loss in the form of central, paracentral, or arcuate scotoma, with preservation of peripheral vision <TextLink reference="1"></TextLink>. It usually occurs 24–48 hours after head or thoracic trauma, long bone fracture, or during systemic conditions such as acute pancreatitis, renal dysfunction, TMA, and DCTDs <TextLink reference="2"></TextLink>, <TextLink reference="3"></TextLink>, <TextLink reference="9"></TextLink>.</Pgraph><Pgraph>Its pathogenesis has not yet been well-defined <TextLink reference="3"></TextLink>. Some evidence supports the idea that in addition to complement deposition, occlusion of precapillary arterioles by fibrin aggregates, leukocytes, and platelets leads to intravascular coagulation and focal ischemia <TextLink reference="2"></TextLink>, <TextLink reference="3"></TextLink>. Particularly, in inflammatory diseases, the initial occlusive phenomenon may be related to endothelial dysfunction <TextLink reference="2"></TextLink>, <TextLink reference="3"></TextLink>.</Pgraph><Pgraph>The diagnosis of Purtscher’s retinopathy is based on ophthalmoscopic findings, such as “flaming” and diffuse retinal hemorrhages, and perimacular cotton wool nodules <TextLink reference="3"></TextLink>. Purtscher’s flecken pathognomonic lesions are described in 50% of the cases <TextLink reference="3"></TextLink>. It consists of multip<TextGroup><PlainText>le d</PlainText></TextGroup>iscrete areas of retinal whitening in the superficial aspect of the inner retina between the arterioles and venules <TextLink reference="3"></TextLink>. These fundoscopic abnormalities are confined to the posterior pole, specifically within the macula <TextLink reference="3"></TextLink>. Fluorescein angiography is an additional test that may reveal arteriolar occlusions with areas of hypofluorescence <TextLink reference="3"></TextLink>. </Pgraph><Pgraph>Currently, there is no well-established treatment for Purtscher-like retinopathy <TextLink reference="3"></TextLink>. High-dose corticosteroids have variable efficacies and may improve visual outcomes in some patients <TextLink reference="3"></TextLink>. In general, emphasis is placed on the treatment of underlying diseases <TextLink reference="3"></TextLink>. However, most cases of Purtscher-like retinopathy show spontaneous remission <TextLink reference="3"></TextLink>. Acute lesions tend to disappear within 1<TextGroup><PlainText>–3 m</PlainText></TextGroup>onths, even without treatment, and are replaced by atrophy of the pigment epithelium, pallor of the optic disc, and attenuation of retinal vessels <TextLink reference="3"></TextLink>. However, when Purtscher-like retinopathy is associated with DCTD or TMA, it usually has a worse prognosis, with only partial recovery observed in approximately 70% of cases <TextLink reference="10"></TextLink>. </Pgraph><Pgraph>The treatment of ASD in an acute setting consist<TextGroup><PlainText>s of n</PlainText></TextGroup>onsteroidal anti-inflammatory drugs and corticosteroids <TextLink reference="11"></TextLink>. After achieving clinical and biochemical remission, gradual tapering of the corticosteroids is initiate<TextGroup><PlainText>d. B</PlainText></TextGroup>lockade of methotrexate, Interleukin-1 (IL-1), and Interleuki<TextGroup><PlainText>n-6 </PlainText></TextGroup>(IL-6) is reserved for relapsing and chronic disease <TextLink reference="10"></TextLink>. In all cases described, corticosteroids were used, and in severe cases, additional immunosuppression was performed with blockade of methotrexate, IL-1, or IL-6 <TextLink reference="11"></TextLink>. Most patients presented with partial recovery <TextLink reference="11"></TextLink>. We used pulse therapy with corticosteroids followed by maintenance of oral steroid therapy and oral methotrexate, but it was ineffective for the recovery of the patient’s vision. Given the persistence of bilateral posterior uveitis despite the control of systemic inflammation, we chose tumor necrosis factor inhibitor (anti-TNF) therapy because it has already proven to be beneficial in non-infectious uveitis <TextLink reference="11"></TextLink>, <TextLink reference="12"></TextLink>. Although we do not know the long-term therapeutic response, the patient showed partial improvement in visual damage. </Pgraph></TextBlock> <TextBlock name="Conclusion" linked="yes"> <MainHeadline>Conclusion</MainHeadline><Pgraph>Purtscher-like retinopathy is a poor prognostic factor for ASD, as it can lead to permanent visual damage. Therefore, early and aggressive immunosuppressive therapy is mandatory. </Pgraph></TextBlock> <TextBlock name="Notes" linked="yes"> <MainHeadline>Notes</MainHeadline><SubHeadline>Ethics statement and informed consent</SubHeadline><Pgraph>The case report is a minimal risk study which was conducted in full compliance with the principles of the Declaration of Helsinki and Good Clinical Practice. All identifying patient information was kept confidential. Informed consent was obtained from the patient.</Pgraph><SubHeadline>Competing interests</SubHeadline><Pgraph>The authors declare that they have no competing interests.</Pgraph></TextBlock> <References linked="yes"> <Reference refNo="1"> <RefAuthor>Gonçalves De Medeiros HA</RefAuthor> <RefAuthor>Gonçalves De Medeiros JE</RefAuthor> <RefAuthor>Caliari LC</RefAuthor> <RefAuthor>Furtado Da Silva J</RefAuthor> <RefTitle>Purtscher's and Purtscher-like retinopathies</RefTitle> <RefYear>2009</RefYear> <RefJournal>Rev Bras Oftalmol</RefJournal> <RefPage>114-9</RefPage> <RefTotal>Gonçalves De Medeiros HA, Gonçalves De Medeiros JE, Caliari LC, Furtado Da Silva J. Purtscher's and Purtscher-like retinopathies. Rev Bras Oftalmol. 2009;68(2):114-9. DOI: 10.1590/S0034-72802009000200010</RefTotal> <RefLink>https://doi.org/10.1590/S0034-72802009000200010</RefLink> </Reference> <Reference refNo="2"> <RefAuthor>Proença Pina J</RefAuthor> <RefAuthor>Ssi-Yan-Kai K</RefAuthor> <RefAuthor>de Monchy I</RefAuthor> <RefAuthor>Charpentier B</RefAuthor> <RefAuthor>Offret H</RefAuthor> <RefAuthor>Labetoulle M</RefAuthor> <RefTitle>Pseudo-rétinopathie de Purtscher: à propos d'un cas et revue de la littérature</RefTitle> <RefYear>2008</RefYear> <RefJournal>J Fr Ophtalmol</RefJournal> <RefPage>609-13</RefPage> <RefTotal>Proença Pina J, Ssi-Yan-Kai K, de Monchy I, Charpentier B, Offret H, Labetoulle M. Pseudo-rétinopathie de Purtscher: à propos d'un cas et revue de la littérature [Purtscher-like retinopathy: case report and review of the literature]. J Fr Ophtalmol. 2008 Jun;31(6 Pt 1):609-13. DOI: 10.1016/s0181-5512(08)75463-9</RefTotal> <RefLink>https://doi.org/10.1016/s0181-5512(08)75463-9</RefLink> </Reference> <Reference refNo="3"> <RefAuthor>Agrawal A</RefAuthor> <RefAuthor>McKibbin MA</RefAuthor> <RefTitle>Purtscher's and Purtscher-like retinopathies: a review</RefTitle> <RefYear>2006</RefYear> <RefJournal>Surv Ophthalmol</RefJournal> <RefPage>129-36</RefPage> <RefTotal>Agrawal A, McKibbin MA. Purtscher's and Purtscher-like retinopathies: a review. Surv Ophthalmol. 2006;51(2):129-36. DOI: 10.1016/j.survophthal.2005.12.003</RefTotal> <RefLink>https://doi.org/10.1016/j.survophthal.2005.12.003</RefLink> </Reference> <Reference refNo="4"> <RefAuthor>Escoda T</RefAuthor> <RefAuthor>Seguier J</RefAuthor> <RefAuthor>Swiader L</RefAuthor> <RefAuthor>Briantais A</RefAuthor> <RefAuthor>Sampo M</RefAuthor> <RefAuthor>Harlé JR</RefAuthor> <RefAuthor>Durand JM</RefAuthor> <RefTitle>Pseudo-rétinopathie de Purtscher dans le cadre d’une maladie de Still de l’adulte : à propos d’un cas et revue de la littérature</RefTitle> <RefYear>2020</RefYear> <RefJournal>Rev Med Interne</RefJournal> <RefPage>279-83</RefPage> <RefTotal>Escoda T, Seguier J, Swiader L, Briantais A, Sampo M, Harlé JR, Durand JM. Pseudo-rétinopathie de Purtscher dans le cadre d’une maladie de Still de l’adulte : à propos d’un cas et revue de la littérature [Purtscher-like retinopathy associated with adult onset still disease: Case report and review of the literature]. Rev Med Interne. 2020 Apr;41(4):279-83. DOI: 10.1016/j.revmed.2019.12.024</RefTotal> <RefLink>https://doi.org/10.1016/j.revmed.2019.12.024</RefLink> </Reference> <Reference refNo="5"> <RefAuthor>Jiang W</RefAuthor> <RefAuthor>Tang L</RefAuthor> <RefAuthor>Duan X</RefAuthor> <RefAuthor>Jiang B</RefAuthor> <RefTitle>A case of uveitis in adult-onset Still's disease with ophthalmologic symptoms</RefTitle> <RefYear>2013</RefYear> <RefJournal>Rheumatol Int</RefJournal> <RefPage>1867-72</RefPage> <RefTotal>Jiang W, Tang L, Duan X, Jiang B. A case of uveitis in adult-onset Still's disease with ophthalmologic symptoms. Rheumatol Int. 2013 Jul;33(7):1867-72. DOI: 10.1007/s00296-011-2351-7</RefTotal> <RefLink>https://doi.org/10.1007/s00296-011-2351-7</RefLink> </Reference> <Reference refNo="6"> <RefAuthor>Yachoui R</RefAuthor> <RefTitle>Purtscher-like retinopathy associated with adult-onset still disease</RefTitle> <RefYear>2018</RefYear> <RefJournal>Retin Cases Brief Rep</RefJournal> <RefPage>379-81</RefPage> <RefTotal>Yachoui R. Purtscher-like retinopathy associated with adult-onset still disease. Retin Cases Brief Rep. 2018;12(4):379-81. DOI: 10.1097/ICB.0000000000000515</RefTotal> <RefLink>https://doi.org/10.1097/ICB.0000000000000515</RefLink> </Reference> <Reference refNo="7"> <RefAuthor>Buyukavsar C</RefAuthor> <RefAuthor>Karagoz E</RefAuthor> <RefAuthor>Sonmez M</RefAuthor> <RefAuthor>Kar T</RefAuthor> <RefAuthor>Kaya A</RefAuthor> <RefAuthor>Düzgun E</RefAuthor> <RefAuthor>Yildirim Y</RefAuthor> <RefTitle>A Rare Ocular Manifestation of Adult Onset Still's Disease: Purtscher's-like Retinopathy</RefTitle> <RefYear>2018</RefYear> <RefJournal>Ocul Immunol Inflamm</RefJournal> <RefPage>286-91</RefPage> <RefTotal>Buyukavsar C, Karagoz E, Sonmez M, Kar T, Kaya A, Düzgun E, Yildirim Y. A Rare Ocular Manifestation of Adult Onset Still's Disease: Purtscher's-like Retinopathy. Ocul Immunol Inflamm. 2018;26(2):286-91. DOI: 10.1080/09273948.2016.1213857</RefTotal> <RefLink>https://doi.org/10.1080/09273948.2016.1213857</RefLink> </Reference> <Reference refNo="8"> <RefAuthor>Akiyama K</RefAuthor> <RefAuthor>Iwasaki Y</RefAuthor> <RefAuthor>Tanaka R</RefAuthor> <RefTitle>Severe Adult Still's Disease Complicated by Purtscher-Like Retinopathy Treated with Intravenous Pulse Methylprednisolone and Tocilizumab</RefTitle> <RefYear>2021</RefYear> <RefJournal>Case Rep Ophthalmol</RefJournal> <RefPage>531-7</RefPage> <RefTotal>Akiyama K, Iwasaki Y, Tanaka R. Severe Adult Still's Disease Complicated by Purtscher-Like Retinopathy Treated with Intravenous Pulse Methylprednisolone and Tocilizumab. Case Rep Ophthalmol. 2021;12(2):531-7. DOI: 10.1159/000516851</RefTotal> <RefLink>https://doi.org/10.1159/000516851</RefLink> </Reference> <Reference refNo="9"> <RefAuthor>Miguel AI</RefAuthor> <RefAuthor>Henriques F</RefAuthor> <RefAuthor>Azevedo LF</RefAuthor> <RefAuthor>Loureiro AJ</RefAuthor> <RefAuthor>Maberley DA</RefAuthor> <RefTitle>Systematic review of Purtscher's and Purtscher-like retinopathies</RefTitle> <RefYear>2013</RefYear> <RefJournal>Eye (Lond)</RefJournal> <RefPage>1-13</RefPage> <RefTotal>Miguel AI, Henriques F, Azevedo LF, Loureiro AJ, Maberley DA. Systematic review of Purtscher's and Purtscher-like retinopathies. Eye (Lond). 2013 Jan;27(1):1-13. DOI: 10.1038/eye.2012.222</RefTotal> <RefLink>https://doi.org/10.1038/eye.2012.222</RefLink> </Reference> <Reference refNo="10"> <RefAuthor>Tang AA</RefAuthor> <RefAuthor>Lin AL</RefAuthor> <RefTitle>Purtscher-like retinopathy in adult-onset Still's disease, complicated by treatment-related central serous chorioretinopathy</RefTitle> <RefYear>2020</RefYear> <RefJournal>Am J Ophthalmol Case Rep</RefJournal> <RefPage>100631</RefPage> <RefTotal>Tang AA, Lin AL. Purtscher-like retinopathy in adult-onset Still's disease, complicated by treatment-related central serous chorioretinopathy. Am J Ophthalmol Case Rep. 2020 Jun;18:100631. DOI: 10.1016/j.ajoc.2020.100631</RefTotal> <RefLink>https://doi.org/10.1016/j.ajoc.2020.100631</RefLink> </Reference> <Reference refNo="11"> <RefAuthor>Trivedi A</RefAuthor> <RefAuthor>Katelaris C</RefAuthor> <RefTitle>The use of biologic agents in the management of uveitis</RefTitle> <RefYear>2019</RefYear> <RefJournal>Intern Med J</RefJournal> <RefPage>1352-63</RefPage> <RefTotal>Trivedi A, Katelaris C. The use of biologic agents in the management of uveitis. Intern Med J. 2019 Nov;49(11):1352-63. DOI: 10.1111/imj.14215</RefTotal> <RefLink>https://doi.org/10.1111/imj.14215</RefLink> </Reference> <Reference refNo="12"> <RefAuthor>Kruh JN</RefAuthor> <RefAuthor>Yang P</RefAuthor> <RefAuthor>Suelves AM</RefAuthor> <RefAuthor>Foster CS</RefAuthor> <RefTitle>Infliximab for the treatment of refractory noninfectious Uveitis: a study of 88 patients with long-term follow-up</RefTitle> <RefYear>2014</RefYear> <RefJournal>Ophthalmology</RefJournal> <RefPage>358-34</RefPage> <RefTotal>Kruh JN, Yang P, Suelves AM, Foster CS. Infliximab for the treatment of refractory noninfectious Uveitis: a study of 88 patients with long-term follow-up. Ophthalmology. 2014 Jan;121(1):358-34. DOI: 10.1016/j.ophtha.2013.07.019</RefTotal> <RefLink>https://doi.org/10.1016/j.ophtha.2013.07.019</RefLink> </Reference> <Reference refNo="13"> <RefAuthor>Diamond JR</RefAuthor> <RefTitle>Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura (HUS/TTP) complicating adult Still's disease: remission induced with intravenous immunoglobulin G</RefTitle> <RefYear>10(5)</RefYear> <RefJournal>J Nephrol</RefJournal> <RefPage>253-7</RefPage> <RefTotal>Diamond JR. Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura (HUS/TTP) complicating adult Still's disease: remission induced with intravenous immunoglobulin G. J Nephrol. 10(5):253-7.</RefTotal> </Reference> <Reference refNo="14"> <RefAuthor>Okwuosa TM</RefAuthor> <RefAuthor>Lee EW</RefAuthor> <RefAuthor>Starosta M</RefAuthor> <RefAuthor>Chohan S</RefAuthor> <RefAuthor>Volkov S</RefAuthor> <RefAuthor>Flicker M</RefAuthor> <RefAuthor>Curran J</RefAuthor> <RefAuthor>Rezaei KA</RefAuthor> <RefAuthor>Sweiss NJ</RefAuthor> <RefTitle>Purtscher-like retinopathy in a patient with adult-onset Still's disease and concurrent thrombotic thrombocytopenic purpura</RefTitle> <RefYear>2007</RefYear> <RefJournal>Arthritis Rheum</RefJournal> <RefPage>182-5</RefPage> <RefTotal>Okwuosa TM, Lee EW, Starosta M, Chohan S, Volkov S, Flicker M, Curran J, Rezaei KA, Sweiss NJ. Purtscher-like retinopathy in a patient with adult-onset Still's disease and concurrent thrombotic thrombocytopenic purpura. Arthritis Rheum. 2007 Feb;57(1):182-5. DOI: 10.1002/art.22477</RefTotal> <RefLink>https://doi.org/10.1002/art.22477</RefLink> </Reference> <Reference refNo="15"> <RefAuthor>Liu FC</RefAuthor> <RefAuthor>Chiang SY</RefAuthor> <RefAuthor>Chang DM</RefAuthor> <RefAuthor>Lai JH</RefAuthor> <RefAuthor>Hou TY</RefAuthor> <RefAuthor>Chen CH</RefAuthor> <RefTitle>Purtscher's-like retinopathy as an initial presentation of adult-onset Still's disease: a case report and review of the literature</RefTitle> <RefYear>2007</RefYear> <RefJournal>Clin Rheumatol</RefJournal> <RefPage>1204-6</RefPage> <RefTotal>Liu FC, Chiang SY, Chang DM, Lai JH, Hou TY, Chen CH. Purtscher's-like retinopathy as an initial presentation of adult-onset Still's disease: a case report and review of the literature. Clin Rheumatol. 2007 Jul;26(7):1204-6. DOI: 10.1007/s10067-006-0345-8</RefTotal> <RefLink>https://doi.org/10.1007/s10067-006-0345-8</RefLink> </Reference> <Reference refNo="16"> <RefAuthor>El Karoui K</RefAuthor> <RefAuthor>Karras A</RefAuthor> <RefAuthor>Lebrun G</RefAuthor> <RefAuthor>Charles P</RefAuthor> <RefAuthor>Arlet JB</RefAuthor> <RefAuthor>Jacquot C</RefAuthor> <RefAuthor>Orssaud C</RefAuthor> <RefAuthor>Nochy D</RefAuthor> <RefAuthor>Pouchot J</RefAuthor> <RefTitle>Thrombotic microangiopathy and purtscher-like retinopathy associated with adult-onset Still's disease: a role for glomerular vascular endothelial growth factor?</RefTitle> <RefYear>2009</RefYear> <RefJournal>Arthritis Rheum</RefJournal> <RefPage>1609-13</RefPage> <RefTotal>El Karoui K, Karras A, Lebrun G, Charles P, Arlet JB, Jacquot C, Orssaud C, Nochy D, Pouchot J. Thrombotic microangiopathy and purtscher-like retinopathy associated with adult-onset Still's disease: a role for glomerular vascular endothelial growth factor? Arthritis Rheum. 2009 Nov;61(11):1609-13. DOI: 10.1002/art.24826</RefTotal> <RefLink>https://doi.org/10.1002/art.24826</RefLink> </Reference> </References> <Media> <Tables> <Table format="png"> <MediaNo>1</MediaNo> <MediaID>1</MediaID> <Caption><Pgraph><Mark1>Table 1: Main laboratory findings</Mark1></Pgraph></Caption> </Table> <Table format="png"> <MediaNo>2</MediaNo> <MediaID>2</MediaID> <Caption><Pgraph><Mark1>Table 2: Clinical profile of patients with Purtscher-like retinopathy as a manifestation of adult Still’s disease</Mark1></Pgraph></Caption> </Table> <NoOfTables>2</NoOfTables> </Tables> <Figures> <Figure width="557" height="223" format="png"> <MediaNo>1</MediaNo> <MediaID>1</MediaID> <Caption><Pgraph><Mark1>Figure 1: a: Fundoscopy of the right eye revealed papilla with physiological cupping and presence of peripapillary shunts, diffuse arteriolar attenuation associated venous engorgement, retinal hemorrhages in the four quadrants, exudates in the macular region. b: Fundoscopy of the left eye revealed papilla with clear physiological cupping and presence of peripapillary shunts, diffuse arteriolar attenuation associated venous engorgement, retinal hemorrhages in the four quadrants, exudates in the macular region.</Mark1></Pgraph></Caption> </Figure> <Figure width="561" height="384" format="png"> <MediaNo>2</MediaNo> <MediaID>2</MediaID> <Caption><Pgraph><Mark1>Figure 2: Sequence of angiography images in the late phase showed delayed circulatory times with slower filling of vessels in all phases of the angiogram, areas of non-perfusion (*), and late leakage (arrowhead).</Mark1></Pgraph></Caption> </Figure> <NoOfPictures>2</NoOfPictures> </Figures> <InlineFigures> <NoOfPictures>0</NoOfPictures> </InlineFigures> <Attachments> <NoOfAttachments>0</NoOfAttachments> </Attachments> </Media> </OrigData> </GmsArticle>